Valuation: AstraZeneca PLC

Market Cap 263B 230B 213B 195B 369B 25,331B 375B 2,534B 996B 12,370B 987B 966B 42,707B P/E 2026 *
21.2x
P/E 2027 * 18.6x
Enterprise Value 282B 247B 228B 209B 396B 27,181B 403B 2,719B 1,068B 13,273B 1,059B 1,036B 45,825B EV / Sales 2026 *
4.46x
EV / Sales 2027 * 4.11x
Free-Float
96.63%
Yield 2026 *
1.97%
Yield 2027 * 2.08%

Last Transcript: AstraZeneca PLC

1 day+0.53%
1 week-5.44%
Current month-10.44%
1 month-4.94%
3 months-15.03%
6 months-10.13%
Current year-8.43%
1 week 9,892
Extreme 9892
13,414
1 month 9,892
Extreme 9892
15,126
Current year 9,892
Extreme 9892
15,732
1 year 9,892
Extreme 9892
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-5.44%+21.00%+23.80% 263B
+1.31%-3.85%+48.15%+161.68% 1,031B
+0.65%-4.11%+50.77%+56.18% 595B
+3.13%+0.61%+31.93%+86.48% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+1.59%+4.89%-22.56%-37.35% 224B
+2.73%+1.21%+23.08%+61.53% 193B
+2.11%-0.58%+22.04%+73.03% 164B
+0.83%+3.48%+1.97%-30.02% 141B
Average +1.34%-3.09%+23.54%+46.41% 364.58B
Weighted average by Cap. +1.26%-4.02%+32.98%+75.48%

Financials

2026 *2027 *
Net sales 63.22B 55.26B 51.1B 46.89B 88.75B 6,092B 90.29B 609B 239B 2,975B 237B 232B 10,270B 66.81B 58.4B 54B 49.56B 93.79B 6,437B 95.42B 644B 253B 3,144B 251B 245B 10,853B
Net income 12.43B 10.87B 10.05B 9.22B 17.45B 1,198B 17.76B 120B 47.08B 585B 46.69B 45.66B 2,020B 13.94B 12.18B 11.27B 10.34B 19.57B 1,343B 19.91B 134B 52.78B 656B 52.34B 51.19B 2,264B
Net Debt 19.2B 16.78B 15.52B 14.24B 26.95B 1,850B 27.42B 185B 72.69B 903B 72.09B 70.5B 3,118B 11.9B 10.4B 9.62B 8.83B 16.71B 1,147B 17B 115B 45.08B 560B 44.7B 43.72B 1,934B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-16 GBX 12,628.00 +0.49% 1,121,343
26-07-15 GBX 12,566.00 +1.63% 3,346,169
26-07-14 GBX 12,364.00 -1.95% 3,313,274
26-07-13 GBX 12,610.00 -1.75% 2,741,916
26-07-10 GBX 12,834.00 -3.89% 3,355,019
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
169.49USD
Average target price
212.17USD
Spread / Average Target
+25.18%

Quarterly revenue - Rate of surprise